Jump to main content
eTG Complete
Index
Search
Home
Rheumatology
Crystal diseases including gout
Gout
Pharmacological management for chronic gout
Drug choice for urate-lowering therapy
Rheumatology
Assessment and initial management of musculoskeletal symptoms
Practical information on drugs used for musculoskeletal and rheumatological conditions
Adult-onset Still disease
Antiphospholipid syndrome
Autoinflammatory periodic fever syndromes
Back pain
Behçet syndrome
Crystal diseases including gout
Gout
Overview of gout
Pathogenesis of and risk factors for gout
Clinical features of acute gout
Clinical features of chronic gout
Diagnosis of gout
Management overview for gout
Information for patients diagnosed with gout
Pharmacological management for acute gout
Drug regimens for acute gout
Pharmacological management for chronic gout
Principles of pharmacological management for chronic gout
Drug choice for urate-lowering therapy
Allopurinol for first-line urate-lowering therapy
Second-line urate-lowering therapy
Prevention of gout flares when starting or changing urate-lowering therapy
Drug regimens for chronic gout
References
Asymptomatic hyperuricaemia
Calcium pyrophosphate deposition
Fibromyalgia
Idiopathic inflammatory myopathies
Immunoglobulin G
4
-related disease
Inflammatory connective tissue diseases
Juvenile idiopathic arthritis
Overview of limb conditions
Upper limb conditions
Lower limb conditions
Neck pain
Osteoarthritis
Musculoskeletal conditions in children and adolescents
Polymyalgia rheumatica
Pregnancy-related low back pain and pelvic pain
Raynaud phenomenon
Rheumatoid arthritis
Spondyloarthritis
Systemic vasculitides
Transition of adolescents to adult rheumatology management
Viral arthritis
Drug choice for urate-lowering therapy
Allopurinol for first-line urate-lowering therapy
Second-line urate-lowering therapy
